Newsbenzinga
What's Going On With AbbVie Stock Friday?
· Published
Article summary
AbbVie shares are edging higher Friday following Thursday's positive Phase 3 trial results for its menstrual migraine drug, atogepant.
An excerpt from the original article.
Comments —
Loading comments…